FOXC1 and hydrops fetalis: FoxC1 controls the expression of the ischemia-mediated proangiogenic cytokines and inflammatory/fibrotic factors in the vascular niche, promoting angiogenesis, inhibiting inflammation and fibrosis, impeding the development of HF, preserving LV function and dimensions, and preventing infarct expansion induced by MSC therapy.